Samrat Pharmachem Limited (BOM:530125)

India flag India · Delayed Price · Currency is INR
254.00
-0.15 (-0.06%)
At close: Jul 10, 2026
Market Cap784.78M -24.4%
Revenue (ttm)2.90B +1.3%
Net Income-33.12M
EPS-10.72
Shares Out 3.09M
PE Ration/a
Forward PEn/a
Dividend1.00 (0.39%)
Ex-Dividend DateSep 18, 2025
Volume1,256
Open245.00
Previous Close254.15
Day's Range245.00 - 259.80
52-Week Range190.00 - 388.10
Beta-0.22
Analystsn/a
Price Targetn/a
Earnings DateAug 14, 2026

About Samrat Pharmachem

Samrat Pharmachem Limited engages in the manufacture and sale of pharmaceutical chemicals in India. It offers 3-5-di iodosalicylic acid, ammonium iodide, cadmium iodide, calcium iodate, clioquinol, copper iodide, ethyl iodide, ethylenediamine dihydroiodide, hydroiodic acid, iodine, iodine monochloride, iodoquinol, methyl iodide, n-iodo succinimide, periodic acid, potassium iodate and iodide, potassium metaper iodate, povidone iodine, sodium iodate and iodide, and sodium metaper iodate. The company serves the agrochemical, animal feed, chemical,... [Read more]

Industry Industrial Inorganic Chemicals
Founded 1992
Employees 28
Stock Exchange Bombay Stock Exchange
Ticker Symbol 530125
Full Company Profile

Financial Performance

Financial Statements